This mechanism leads to reduced appetite, increased feelings of fullness, and ultimately supports weight loss when combined with dietary modifications and increased physical activity
The phase 2 study in type 2 diabetes patients showed significant appetite reductions, but the overall weight loss was slightly lower than in the obesity-only trial (16.9% versus 24.2% at the highest doses over comparable timeframes)
[Reference for naltrexone's role in appetite/reward pathways at higher LDN doses] 6
Lm u mu da, trng sng da, gim thm nm, tn nhang, cho ln da rng r, sng khe
In addition to their anti-inflammatory effects, these compounds have inhibitory effects on the following pathways: inflammasome (NLRP3), Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, endothelial cell vascular cell adhesion molecule-1 (VCAM-1) or intercellular adhesion molecule-1 (ICAM-1), matrix metalloproteinases involved in remodelling and metastasis (MMP 2, MMP 9), and chronic cycloxogenase derived prostaglandins that promote angiogenesis and immunosuppression (182)
